COMPANY OVERVIEW
Grand Life Sciences (Liaoning) Co., Ltd. is a wholly-owned subsidiary of Grand Life Sciences Group, and a full-value-chain pharmaceutical enterprise integrating R&D, production and marketing. Focusing on the fields of hemostasis, anesthesia & analgesia and wound management, the company has multiple marketed products including the national Class 1 new drug Collagenase for Injection and enzymatic debridement agent Collagenase Ointment. Its hemostatic product line represented by Hemocoagulase Bothrops Atrox for Injection has maintained a top-tier sales ranking in China for many consecutive years.
The company has a complete industrial layout, with independently operated pharmaceutical sales subsidiaries, R&D centers, modern comprehensive production bases, API (Active Pharmaceutical Ingredient) production bases and overseas raw material supply bases under its jurisdiction. Its business covers multiple regions including Shenyang (Liaoning), Yantai (Shandong), Anshan (Liaoning) and overseas markets, with a marketing network covering more than 10,000 medical terminals across China.
Going forward, the company will adhere to continuous innovation and strategic layout, strive to build an industry-leading brand, create greater value for the society, and make continuous contributions to the global public health cause.
CONTACT INFORMATION
ONLINE MESSAGE
Copyright◎2024 GRAND LIFE SCIENCES (LIAONING) CO., LTD. 辽ICP备14006882号-1 BY:xinnet